Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.720
-0.020 (-1.15%)
At close: Sep 11, 2026, 4:00 PM EDT
1.740
+0.020 (1.16%)
After-hours: Sep 11, 2026, 7:42 PM EDT
Purple Biotech Employees
Purple Biotech had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$2,449,300
Market Cap
6.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 1 | 11.11% | 10 | 0 |
| Dec 31, 2024 | 9 | -11 | -55.00% | 9 | 0 |
| Dec 31, 2023 | 20 | 0 | - | 20 | 0 |
| Dec 31, 2022 | 20 | 1 | 5.26% | 20 | 0 |
| Dec 31, 2021 | 19 | 6 | 46.15% | 19 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| Lexaria Bioscience | 7 |
| Ernexa Therapeutics | 7 |
| Enveric Biosciences | 6 |
PPBT News
- 11 days ago - Why Is Purple Biotech (PPBT) Stock 42% Up Today? - TipRanks
- 11 days ago - Purple Biotech issued notice of allowance from USPTO - TheFly
- 11 days ago - New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies - GlobeNewsWire
- 5 weeks ago - Purple Biotech price target lowered to $17 from $30 at H.C. Wainwright - TheFly
- 3 months ago - Purple Biotech presents new IM1240 data at EACR - TheFly
- 3 months ago - Purple Biotech files $200M mixed securities shelf - TheFly
- 4 months ago - Purple Biotech reports IM1240 demonstrates potent anti-tumor activity - TheFly
- 5 months ago - Purple Biotech announces collaboration with Converge Bio - TheFly